Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saracatinib + Gemcitabine in Advanced Pancreatic Cancer
NCT00265876Phase 2Completed
- Sponsor
- Canadian Cancer Trials Group
- Start
- Apr 2006
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of saracatinib in pancreatic adenocarcinoma (PDAC), sponsored by Canadian Cancer Trials Group. Started Apr 2006; status: completed.
02
Drugs
saracatinib
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT00265876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00265876.